EXHIBIT 99.1

News Bulletin from FRB                                      
The Financial Relations Board, Inc.


Re:  Innotech, Inc.
5568 Airport Road
Roanoke, VA 24012-1311
(Nasdaq:  IIII)

For Further Information:

At the Company:
Steve Bennington
President and C.O.O.
(540) 362-2020

At the Financial Relations Board:

General Information:
Jeff Bogart
(212) 611-8030

Analyst:
Kathy Brunson
(312) 266-7800

Media:
Deanne Eagle
(212) 661-8030

FOR IMMEDIATE RELEASE:        

March 19, 1997


INNOTECH REACTS TO TENDER OFFER RESULTS

ROANOKE, Va., March 19, 1997-- Innotech, Inc. (Nasdaq:
IIII), a producer of lens products, desktop lens casting
systems and related consumables, expressed satisfaction
today at the outcome of Johnson & Johnson's $135 million
tender offer for the company's stock.

"We're delighted at our shareholders' response to Johnson &
Johnson's tender offer for our company's stock," Ronald D.
Blum, Innotech's chairman and chief executive officer, said. 
"Over 94 percent of the outstanding shares have been
tendered and accepted--a highly successful conclusion to the
tender offer.  Together with the 5% of the Company's stock
previously owned by Johnson & Johnson, it owns approximately
99% of the Company's shares."

Based in Roanoke, Va., Innotech, Inc. develops, manufactures
and sells lens products, desktop lens casting systems and
related consumables that enable optometrists, opticians,
ophthalmologists and other optical retailers to custom
fabricate easily, quickly and less expensively high quality
prescription eyeglass lenses at the point of sale.

To receive additional information on Innotech, Inc., via fax
at no charge, dial 1-800-PRO-INFO and enter code IIII.

                             ###

Editors note:  A copy of the Johnson & Johnson release
announcing the tender offer results is attached.